PART 201 - LABELING
- Subpart A - General Labeling Provisions (§§ 201.1 — 201.26)
- Subpart B - Labeling Requirements for Prescription Drugs and/or Insulin (§§ 201.50 — 201.58)
- Subpart C - Labeling Requirements for Over-the-Counter Drugs (§§ 201.60 — 201.80)
- Subpart D - Exemptions From Adequate Directions for Use (§§ 201.100 — 201.129)
- Subpart E - Other Exemptions (§§ 201.150 — 201.161)
- Subpart F - Labeling Claims for Drugs in Drug Efficacy Study (§ 201.200)
- Subpart G - Specific Labeling Requirements for Specific Drug Products (§§ 201.300 — 201)